[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
April 5, 2006

Clopidogrel Treatment Prior to Percutaneous Coronary Intervention: When Enough Isn't Enough

Author Affiliations

Author Affiliations: Division of Cardiovascular Medicine, Gill Heart Institute, and Department of Statistics, University of Kentucky, Lexington.


Published online March 13, 2006 (doi:10.1001/jama.295.13.jed60017).

JAMA. 2006;295(13):1581-1582. doi:10.1001/jama.295.13.jed60017

Worldwide, more than 2 million patients will be treated with a percutaneous coronary intervention (PCI) this year, with approximately half of these performed in the United States.1 For almost three fourths of these patients, the diagnosis necessitating the procedure will be an acute coronary syndrome (ACS)—either unstable angina or a myocardial infarction (MI).2